Trial reportThe science of diabetes self-management and care2023
Sleep-Opt-In: A Randomized Controlled Pilot Study to Improve Sleep and Glycemic Variability in Adults With Type 1 Diabetes.
Trial report in The science of diabetes self-management and care, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 20 citations in OpenAlex.
- Sleep Optimization to Improve Glycemic Targets in Adults With Type 1 Diabetes: A Randomized Controlled Parallel Intervention Trial.Diabetes care · 2026Trial
- A randomized pilot sleep and circadian behavior clinical trial to improve glycemic and psychological outcomes in young adults with type 1 diabetes (NCT04975230).Diabetes & metabolic syndrome · 2025Trial
- A Randomized Pilot Cognitive Behavioral Sleep Health Trial for Young Adults with Type 1 Diabetes.Behavioral sleep medicineTrial
- Latent profiles of actigraphy-derived sleep regularity, timing, and duration in adults with type 2 diabetes: clinical and psychosocial correlates.Sleep medicine · 2026Article
- Circadian rhythm amplification in diabetic retinopathy: a pilot study.Sleep advances : a journal of the Sleep Research Society · 2026Article
- Using consumer sleep trackers for sleep extension interventions: retention, adherence, and user experiences.Sleep advances : a journal of the Sleep Research Society · 2026Article
- Multidimensional sleep health in type 2 diabetes: The role of sleep variability in glycemic control.Sleep medicine · 2025Article
- Multidimensional Sleep Health, Glycemic Control, and Self-reported Outcomes in Type 1 Diabetes: A Cross-sectional Study.The Journal of clinical endocrinology and metabolism · 2025Article
- Poor sleep quality is a predictor of severe hypoglycemia during comprehensive diabetes care in type 1 diabetes.Sleep & breathing = Schlaf & Atmung · 2025Article
- Sleep patterns in adults and children with less common forms of diabetes.Frontiers in endocrinology · 2025Review
- Sleep extension and cardiometabolic health: what it is, possible mechanisms and real-world applications.The Journal of physiology · 2024Review
- Sleep Disturbances in Type 1 Diabetes and Mitigating Cardiovascular Risk.The Journal of clinical endocrinology and metabolism · 2024Review
- Sleep Health Composite and Diabetes Symptom Burden in Young Adults With Type 1 Diabetes.Western journal of nursing research · 2024Article
- Greater sleep variability is associated with higher systemic inflammation in type 2 diabetes.Journal of sleep research · 2024Article
- Exploring Technology's Influence on Health Behaviours and Well-being in Type 1 Diabetes: a Review.Current diabetes reports · 2024Review
- Association between sleep variability and time in range of glucose levels in patients with type 1 diabetes: Cross-sectional study.Sleep health · 2023Article
- Stress and human health in diabetes: A report from the 19Journal of clinical and translational science · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 3 institutions in 1 country.
Funding
Abstract
purposeThe purpose of this study was to evaluate the feasibility and acceptability of a technology-assisted behavioral sleep intervention (Sleep-Opt-In) and to examine the effects of Sleep-Opt-In on sleep duration and regularity, glucose indices, and patient-reported outcomes. Short sleep duration and irregular sleep schedules are associated with reduced glycemic control and greater glycemic variability.
methodsA randomized controlled parallel-arm pilot study was employed. Adults with type 1 diabetes (n = 14) were recruited from the Midwest and randomized 3:2 to the sleep-optimization (Sleep-Opt-In) or Healthy Living attention control group. Sleep-Opt-In was an 8-week, remotely delivered intervention consisting of digital lessons, sleep tracker, and weekly coaching phone calls by a trained sleep coach. Assessments of sleep (actigraphy), glucose (A1C, continuous glucose monitoring), and patient-reported outcomes (questionnaires for daytime sleepiness, fatigue, diabetes distress, and depressive mood) were completed at baseline and at completion of the intervention.
resultsSleep-Opt-In was feasible and acceptable. Those in Sleep-Opt-In with objectively confirmed short or irregular sleep demonstrated an improvement in sleep regularity (25 minutes), reduced glycemic variability (3.2%), and improved time in range (6.9%) compared to the Healthy Living attention control group. Patient-reported outcomes improved only for the Sleep-Opt-In group. Fatigue and depressive mood improved compared to the control.
conclusionsSleep-Opt-In is feasible, acceptable, and promising for further evaluation as a means to improve sleep duration or regularity in the population of people with type 1 diabetes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.